Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Stockholder Note Receivable
Retained Earnings/(Deficit)
Accumulated Other Comprehensive Loss
Balance (in shares) at Dec. 31, 2019   141,596,000        
Balance at Dec. 31, 2019 $ 1,750,183,000 $ 1,416,000 $ 1,479,941,000 $ (15,000,000) $ 288,478,000 $ (4,652,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (360,192,000)       (360,192,000)  
Other comprehensive income (loss) 1,422,000         1,422,000
Common stock issuance, net (in shares)   3,600,000        
Common stock issuance, net 90,000,000 $ 36,000 89,964,000      
Balance (in shares) at Dec. 31, 2020   145,196,000        
Balance at Dec. 31, 2020 1,481,413,000 $ 1,452,000 1,569,905,000 (15,000,000) (71,714,000) (3,230,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (579,369,000)       (579,369,000)  
Other comprehensive income (loss) 214,000         214,000
Share-based compensation 334,339,000   334,339,000      
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards 3,843,000   3,843,000      
Common stock issuance, net (in shares)   40,582,000        
Common stock issuance, net 701,367,000 $ 406,000 700,961,000      
Issuance of common stock in connection with series A preferred stock conversion (in shares)   6,687,000        
Issuance of common stock in connection with Series A Preferred Stock conversion 149,585,000 $ 67,000 149,518,000      
Issuance of restricted stock in connection with restricted series A preferred stock conversion (in shares)   595,000        
Issuance of common shares in connection with the vesting of restricted stock units 0 $ 6,000 (6,000)      
Stockholder note receivable $ 0   (15,000,000) 15,000,000    
Balance (in shares) at Dec. 31, 2021 193,060,000 193,060,000        
Balance at Dec. 31, 2021 $ 2,091,392,000 $ 1,931,000 2,743,560,000 0 (651,083,000) (3,016,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (1,793,000)       (1,793,000)  
Other comprehensive income (loss) (6,206,000)         (6,206,000)
Share-based compensation 37,291,000   37,291,000      
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards $ 646,000   646,000      
Stock option exercises (in shares) 363,000 363,000        
Stock option exercises $ 3,755,000 $ 4,000 3,751,000      
Equity issuance costs (270,000)   (270,000)      
Issuance of restricted stock in connection with restricted series A preferred stock conversion (in shares)   848,000        
Issuance of common shares in connection with the vesting of restricted stock units $ (554,000) $ 8,000 (562,000)      
Balance (in shares) at Dec. 31, 2022 194,271,000 194,271,000        
Balance at Dec. 31, 2022 $ 2,124,261,000 $ 1,943,000 $ 2,784,416,000 $ 0 $ (652,876,000) $ (9,222,000)